Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
about
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitisMesalazine preparations for the treatment of ulcerative colitis: Are all created equal?Colon-targeted oral drug delivery systems: design trends and approachesNMR Solution Structure and Condition-Dependent Oligomerization of the Antimicrobial Peptide Human Defensin 5The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsThe divergence, actions, roles, and relatives of sodium-coupled bicarbonate transportersMucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.Multi-matrix system mesalamine: to use or not to use.pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures.Loss of downregulated in adenoma (DRA) impairs mucosal HCO3(-) secretion in murine ileocolonic inflammation.The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation.pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colonSurvival and synergistic growth of mixed cultures of bifidobacteria and lactobacilli combined with prebiotic oligosaccharides in a gastrointestinal tract simulator.New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and AdherenceGetting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.Prevention of siderophore- mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH.Bacterial protein signals are associated with Crohn's disease.Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoidsLinking microbial community structure to function in representative simulated systems.Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.Depth-dependent differences in community structure of the human colonic microbiota in health.Acid sensing by visceral afferent neurones.Acid-sensitive ion channels and receptorsEvaluation of new therapies for inflammatory bowel disease.Calcium-sensing receptor stimulates Cl(-)- and SCFA-dependent but inhibits cAMP-dependent HCO3(-) secretion in colon.Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.Obesity and the microbiome.Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse TabletsMIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids.The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.Design and Investigation of PolyFermS In Vitro Continuous Fermentation Models Inoculated with Immobilized Fecal Microbiota Mimicking the Elderly Colon.Impact of pH on lactate formation and utilization by human fecal microbial communitiesApical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers.Optimizing management of distal ulcerative colitis.Time-controlled oral delivery systems for colon targeting.Prognostic impact of fecal pH in critically ill patients.Taste receptors in the gastrointestinal tract. V. Acid sensing in the gastrointestinal tractAssessment of Tandem Measurements of pH and Total Gut Transit Time in Healthy Volunteers.Mesalamine with MMX technology for the treatment of ulcerative colitis.
P2860
Q24685584-DCEBAE40-822E-4E14-9607-780E3D03F5DCQ26777634-BF9C7206-19A4-4042-99B8-56CD49F489BEQ27002400-5D19260B-2A22-4864-939A-BD8263127195Q27675169-627D63BE-19D9-46C7-BBDB-9EF10A7CFA6AQ28302792-E07CAC37-FB29-4FD6-9009-9432A583D18CQ30440948-E70C9FA6-F3B4-4FBF-B59D-25CA5BA685FAQ30988830-00C5AD85-156B-4D86-AD8E-3563EC1F43F7Q33438982-55DC585E-34F2-4393-8FFA-05D6EAE099D3Q33634286-81D50EDF-D804-4EEB-8812-24BFB5755503Q33664886-2927EAFD-75AC-47D3-BA51-DCA5C857EB7AQ33858114-1A4B97FA-9022-450D-935E-E67150BAB10CQ33884828-1C93E609-CA54-4A5A-94D2-56CFC40721A3Q33912533-487F4C70-03BA-445D-B7CB-2EC140F11A31Q33916287-1D5267D1-BC74-43BB-91EA-2C617886B3CFQ34024552-337664AD-0DA3-44F9-A308-B1826C7075F7Q34029032-66EA796E-ACBE-4CBF-A507-407AC04F1EF2Q34237245-76D612BE-9CCB-406B-A712-F89E69398BF9Q34291196-165E4CBF-083D-44EC-9DEA-8A8B77687203Q34581809-0B4417D8-52C2-4E0D-9657-7A5FEBC24620Q34649832-9BB69EFE-51E8-426F-A44D-A4F06BDDC5E2Q34979453-230320C0-0006-4094-B93A-C8D6B98C673FQ35040241-F0EB195B-803C-4D48-AC45-999109416734Q35177799-3491EC69-2E06-4176-B45C-831435E6E117Q35178189-9D2EFEAD-62EB-41E5-8BA0-6060F327AEA6Q35216827-CC2418D8-76C9-44BE-B04E-9D3586BD230AQ35622544-E786D15A-223C-4D12-9987-1A85C4324D06Q35638893-9BC8CE5E-57EA-4824-B89E-50EE06EBBAA8Q35665589-1A37FCAD-09EC-4651-BB88-ADC84ECF834CQ35692281-4FB8D100-11CB-4152-85E5-A738CBE0DC0BQ35752912-6507CBB6-AD00-4B03-B399-72E456AB6940Q35820873-199AF62B-4C63-467B-84C7-8E4A0857ACD7Q35838831-B3249250-8DBD-4888-B588-65057265D440Q36137210-6F4E90AF-90B7-4B99-B8EC-9789ABD03D61Q36431083-223383D2-D8B7-4876-9A73-B5D7F7CEDBF4Q36459902-1637CA30-80D2-4F2E-B8B6-4E06D42FA4EAQ36583724-D0B0A64E-E393-4BEA-989D-4F4B06E781EAQ36633838-079A908B-0CD3-4AED-82FD-CFEC6475D18FQ36661313-FAF8E46C-2933-4A8B-BA5C-F1D475A81DFDQ36752016-3B9F1BCF-9936-4334-9580-51B3BFF9880BQ37345925-07596D6E-1DF0-40E7-8FAD-60673B761F46
P2860
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@ast
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@en
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@nl
type
label
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@ast
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@en
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@nl
prefLabel
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@ast
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@en
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@nl
P2093
P2860
P356
P1433
P1476
Intestinal luminal pH in infla ...... inosalicylates and other drugs
@en
P2093
P2860
P356
10.1136/GUT.48.4.571
P407
P577
2001-04-01T00:00:00Z